GSK kicks off over-the-counter drugs sale -sources

LONDON, July 1 (Reuters) - GlaxoSmithKline is pushing ahead with the sale of a clutch of non-prescription products, which may fetch around $2.5 billion, and will send out details to bidders shortly, people familiar with the matter said.